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Cytomegalovirus (CMV) is a common 
herpes virus infection that is usually 
harmless and belongs to a group of 
herpes viruses that includes the herpes 
simplex viruses, varicella-zoster virus 
(which causes chickenpox and shingles), 
and the Epstein-Barr virus (which 
causes infectious mononucleosis). Once 
CMV is in a person's body, it stays there 
throughout their life. (Centers for 
Disease Control and Prevention, 2010). 
CMV is shed in various bodily 
secretions, especially urine and saliva 
(Congenital Cytomegalovirus 
Foundation, 2014). According to the 
Centers for Disease Control and 
Prevention (CDC), the majority of 
otherwise healthy children and adults 
infected with CMV are asymptomatic 
while others may develop a mild illness 
when they get infected. Among every 
100 adults in the United States, 50–80 
are infected with CMV by the time they 
are 40 years old (2010). 
So why is a viral infection that is likely 
to cause a mild illness (if it causes 
symptoms at all) a concern?  Because 
CMV can cause serious disease and 
have life-long effects on a newborn if a 
mother passes CMV on to the fetus 
during pregnancy (congenital CMV 
Infection).  Congenital CMV is a known 
to be one of the most common 
fetomaternal viral infections (Kaneko 
et. al, 2013). This paper aims to bring 
awareness and an improved 
understanding of congenital CMV to 
advanced practice nursing students.  
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Figure 1 (above) shows that for every 1,000 pregnancies that result in a live 
birth, about 400 of those women will not have had a CMV infection prior to 
becoming pregnant. Of those 400 women, about 7 of them will become infected 
with a primary CMV infection during their pregnancy. Of the 7 infected women, 
about 2 will have infants with CMV infection. And, of the 600 women who have 
had CMV infection prior to their pregnancy, about 2 of them will have babies with 
CMV infection. (Cannon, MJ. Congenital cytomegalovirus (CMV) epidemiology and 
awareness. J Clin Virol. 2009:46 [Suppl 4]:S6-10; retrieved from 
www.CDC.gov/cmv/trends-stats.html)  
Despite recommendations that CMV be part of health promotion counseling women of 
child-bearing age receive, less than 50% of obstetricians/gynecologists in the United 
States report counseling their patients about how to prevent CMV infection. 
Awareness of CMV is relatively low among women with only about 13-22% of women 
in the United States having heard of CMV (Thackeray, Wright, Chipman, 2014).  
 
As advanced practice nurses, we have an opportunity to heighten awareness about 
congenital CMV and to educate our patient’s on prevention of transmission of this 
potentially detrimental viral infection while researchers continue to investigate and 
test potential vaccines for this virus.  
Conclusion 
 Sign & Symptoms 
 
According to Schleiss (2015), 
approximately 10% of infants with 
congenital CMV will have symptoms of 
the disease at birth and may include; 
intrauterine growth retardation, enlarged 
liver and spleen, thrombocytopenia, and a 
variety of cutaneous manifestations 
including purpura and petechiae. Schleiss 
(2015) further states, “…the most 
significant manifestations involve the 
CNS. Microcephaly, ventriculomegaly, 
cerebral atrophy, chorioretinitis, and 
sensorineural hearing loss are the most 
common neurological consequences”. 
 
Intracerebral calcifications frequently 
exhibit a periventricular distribution and 
are frequently encountered using CT 
scanning (see Figure 2 below). The 
finding of intracranial calcifications is 
predictive of intellectual and audiological 
deficits later in life. These findings 
forecast a poor neurodevelopmental 




According to Schleiss (2015), CMV has a 
tendency to infect mononuclear cells and 
lymphocytes. It is the biggest member of 
the herpes virus family, with a double-
stranded DNA genome capable of encoding 
more than 200 potential protein products. 
Immediate gene transcription happens 
within the first 4 hours of infection, when 
main regulatory proteins that let the virus 
to take control of cellular machinery are 
made. Late gene products are made about 
24 hours after infection, and these proteins 
are primarily structural and allow for viron 
assembly and egress.  
 
One of the classic symbols of CMV infection 
is the cytomegalic inclusion cell. These 
extremely enlarged cells contain 
intranuclear inclusions that have the 
histopathological appearance of owl’s eyes. 
The existence of these cells indicates 
productive infection (Schleiss, 2015). 
 
The way in which CMV harms the fetus is 
complex and probably includes a 
combination of direct fetal cellular injury 
(especially in the fetal brain), an incomplete 
maternal immune response unable to 
control the infection, and the impact of the 
infection on placental function (including 
oxygen and substrate transportation). CMV 
also encodes gene products that function at 
both the RNA and the protein level, to 
interfere with many cellular processes 
including; modification of the cell cycle, 
interfering with cell apoptosis, 
inflammatory response, mediating vascular 
injury, and proteins that create site-specific 
breakage of chromosome, dysregulation of 
cell proliferation, and most importantly, 
genes that facilitate evasion of host immune 
responses (Schliess, 2015).  
 
Women who have close contact with young children (i.e. daycare workers) are 
particularly at risk to contracting the CMV virus and passing it along to their unborn 
infant. However, routine screening for CMV is not recommended and there is not 
currently a vaccine available. Therefore, prevention of CMV transmission is focused 
on better hygienic practices including; routine hand washing, not sharing cups, 
utensils, or food, and not kissing a child on the lips or near saliva. Prevention-based 
interventions focus on education and counseling (Thackeray, Wright, Chipman, 2014).  
• CMV is the most frequent 
congenital infections in 
newborns and is the leading 
cause of hearing deficit and 
cognitive disability in the 
United States with a direct 
economic cost of $1 billion to 
$2 billion annually (Stowell, 
Forlin-Passoni, Cannon, 2010). 
 
• Out of 1,000 live births, about 
8 (less than 1%) infants will 
have congenital CMV 
infection. 1 or 2 of those 8 
infants will have permanent 
problems (such as 
developmental disabilities or 
hearing loss) due to the 
infection (CDC, 2010).  
Prevalence 
Figure 2. Cranial CT scan of infant born 
with symptomatic congenital 
cytomegalovirus infection. 
Neurological involvement is evident as 
manifested by ventriculomegaly and 
periventricular calcifications.(Schleiss, 
2015). 
Significance of Pathophysiology 
 
Immunity to CMV is multifaceted and 
involves humoral and cell-mediated 
responses. Recently it has been discovered 
that CMV utilizes 2 pathways of entry into 
the cell. The first way is via a fusion-
mediated pathway in fibroblasts. The 
second way is an endocytosis-mediated 
pathway in epithelial and endothelial cells. 
Proteins that are important to these 
pathways (encoded by UL128-131 genes) 
may emerge as particularly useful vaccine 
candidates in future studies (Schleiss, 
2015).  
Basha, J., Iwasenko, J., Robertson, P., Craig, M., & Rawlinson, W. D. (2014). Congenital 
      cytomegalovirus infection is associated with high maternal socio-economic status  
      and corresponding low maternal cytomegalovirus seropositivity. Journal of  
     Paediatrics and Child Health, 50(2014), 368-372. doi: 10.1111/jpc.12502 
 
Cytomegalovirus (CMV) and Pregnancy. (September, 2014). Organization of  
     teratology information. Retrieved July 5, 2015 from: www.OTISpregnancy.org 
 
Lipitz, S., Hoffmann, C., Feldman, B., Tepperberg-Dikawa, M., Schiff, E., & Weisz, B.  
     (2010). Value of prenatal ultrasound and magnetic resonance imaging in  
     assessment of congenital primary cytomegalovirus infection. Ultrasound Obstet  
     Gynecol (2010) 36: 709-717. doi: 10.1002/uog.7657 
 
Schleiss, M.R. (2011, June 1). Could therapeutic vaccination of seropositive persons  
     prevent reinfection and congenital virus transmission? The Journal of Infectious  
     Diseases (2011)203, 1513-1515. doi: 10.1093/infdis/jir144 
CMV Awareness Ribbon @ cmvfoundation.org 
 
